Antimicrobial Peptides Market - Global Outlook and Forecast 2022-2028
Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
This report contains market size and forecasts of Antimicrobial Peptides in global, including the following market information:
Global Antimicrobial Peptides Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Antimicrobial Peptides Market Sales, 2017-2022, 2023-2028, (Mg)
Global top five Antimicrobial Peptides companies in 2021 (%)
The global Antimicrobial Peptides market was valued at 5 million in 2021 and is projected to reach US$ 7 million by 2028, at a CAGR of 5.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Plant Antimicrobial Peptides Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antimicrobial Peptides include AnaSpec, AMP Biotech, Phoenix Biotech, Novabiotics, Chinese Peptide, Ontores, GenScript, Hycult Biotech and Sunsmile, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antimicrobial Peptides manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antimicrobial Peptides Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Mg)
Global Antimicrobial Peptides Market Segment Percentages, by Type, 2021 (%)
Global Antimicrobial Peptides Market Segment Percentages, by Application, 2021 (%)
Global Antimicrobial Peptides Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Antimicrobial Peptides revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Antimicrobial Peptides revenues share in global market, 2021 (%)
Key companies Antimicrobial Peptides sales in global market, 2017-2022 (Estimated), (Mg)
Key companies Antimicrobial Peptides sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Antimicrobial Peptides in global, including the following market information:
Global Antimicrobial Peptides Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Antimicrobial Peptides Market Sales, 2017-2022, 2023-2028, (Mg)
Global top five Antimicrobial Peptides companies in 2021 (%)
The global Antimicrobial Peptides market was valued at 5 million in 2021 and is projected to reach US$ 7 million by 2028, at a CAGR of 5.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Plant Antimicrobial Peptides Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antimicrobial Peptides include AnaSpec, AMP Biotech, Phoenix Biotech, Novabiotics, Chinese Peptide, Ontores, GenScript, Hycult Biotech and Sunsmile, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antimicrobial Peptides manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antimicrobial Peptides Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Mg)
Global Antimicrobial Peptides Market Segment Percentages, by Type, 2021 (%)
- Plant Antimicrobial Peptides
- Microbial Antimicrobial Peptides
- Animal Antimicrobial Peptides
Global Antimicrobial Peptides Market Segment Percentages, by Application, 2021 (%)
- Pharmaceuticals
- Feed Additives
- Others
Global Antimicrobial Peptides Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Antimicrobial Peptides revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Antimicrobial Peptides revenues share in global market, 2021 (%)
Key companies Antimicrobial Peptides sales in global market, 2017-2022 (Estimated), (Mg)
Key companies Antimicrobial Peptides sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- AnaSpec
- AMP Biotech
- Phoenix Biotech
- Novabiotics
- Chinese Peptide
- Ontores
- GenScript
- Hycult Biotech
- Sunsmile
- Ruixing Biotechnology
- Zhongnong Yingtai Biotechnology
- Glam Technology
- ProteLight Pharmaceutical & Biotechnology
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Antimicrobial Peptides Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antimicrobial Peptides Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL ANTIMICROBIAL PEPTIDES OVERALL MARKET SIZE
2.1 Global Antimicrobial Peptides Market Size: 2021 VS 2028
2.2 Global Antimicrobial Peptides Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Antimicrobial Peptides Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Antimicrobial Peptides Players in Global Market
3.2 Top Global Antimicrobial Peptides Companies Ranked by Revenue
3.3 Global Antimicrobial Peptides Revenue by Companies
3.4 Global Antimicrobial Peptides Sales by Companies
3.5 Global Antimicrobial Peptides Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Antimicrobial Peptides Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Antimicrobial Peptides Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antimicrobial Peptides Players in Global Market
3.8.1 List of Global Tier 1 Antimicrobial Peptides Companies
3.8.2 List of Global Tier 2 and Tier 3 Antimicrobial Peptides Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Antimicrobial Peptides Market Size Markets, 2021 & 2028
4.1.2 Plant Antimicrobial Peptides
4.1.3 Microbial Antimicrobial Peptides
4.1.4 Animal Antimicrobial Peptides
4.2 By Type - Global Antimicrobial Peptides Revenue & Forecasts
4.2.1 By Type - Global Antimicrobial Peptides Revenue, 2017-2022
4.2.2 By Type - Global Antimicrobial Peptides Revenue, 2023-2028
4.2.3 By Type - Global Antimicrobial Peptides Revenue Market Share, 2017-2028
4.3 By Type - Global Antimicrobial Peptides Sales & Forecasts
4.3.1 By Type - Global Antimicrobial Peptides Sales, 2017-2022
4.3.2 By Type - Global Antimicrobial Peptides Sales, 2023-2028
4.3.3 By Type - Global Antimicrobial Peptides Sales Market Share, 2017-2028
4.4 By Type - Global Antimicrobial Peptides Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Antimicrobial Peptides Market Size, 2021 & 2028
5.1.2 Pharmaceuticals
5.1.3 Feed Additives
5.1.4 Others
5.2 By Application - Global Antimicrobial Peptides Revenue & Forecasts
5.2.1 By Application - Global Antimicrobial Peptides Revenue, 2017-2022
5.2.2 By Application - Global Antimicrobial Peptides Revenue, 2023-2028
5.2.3 By Application - Global Antimicrobial Peptides Revenue Market Share, 2017-2028
5.3 By Application - Global Antimicrobial Peptides Sales & Forecasts
5.3.1 By Application - Global Antimicrobial Peptides Sales, 2017-2022
5.3.2 By Application - Global Antimicrobial Peptides Sales, 2023-2028
5.3.3 By Application - Global Antimicrobial Peptides Sales Market Share, 2017-2028
5.4 By Application - Global Antimicrobial Peptides Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Antimicrobial Peptides Market Size, 2021 & 2028
6.2 By Region - Global Antimicrobial Peptides Revenue & Forecasts
6.2.1 By Region - Global Antimicrobial Peptides Revenue, 2017-2022
6.2.2 By Region - Global Antimicrobial Peptides Revenue, 2023-2028
6.2.3 By Region - Global Antimicrobial Peptides Revenue Market Share, 2017-2028
6.3 By Region - Global Antimicrobial Peptides Sales & Forecasts
6.3.1 By Region - Global Antimicrobial Peptides Sales, 2017-2022
6.3.2 By Region - Global Antimicrobial Peptides Sales, 2023-2028
6.3.3 By Region - Global Antimicrobial Peptides Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Antimicrobial Peptides Revenue, 2017-2028
6.4.2 By Country - North America Antimicrobial Peptides Sales, 2017-2028
6.4.3 US Antimicrobial Peptides Market Size, 2017-2028
6.4.4 Canada Antimicrobial Peptides Market Size, 2017-2028
6.4.5 Mexico Antimicrobial Peptides Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Antimicrobial Peptides Revenue, 2017-2028
6.5.2 By Country - Europe Antimicrobial Peptides Sales, 2017-2028
6.5.3 Germany Antimicrobial Peptides Market Size, 2017-2028
6.5.4 France Antimicrobial Peptides Market Size, 2017-2028
6.5.5 U.K. Antimicrobial Peptides Market Size, 2017-2028
6.5.6 Italy Antimicrobial Peptides Market Size, 2017-2028
6.5.7 Russia Antimicrobial Peptides Market Size, 2017-2028
6.5.8 Nordic Countries Antimicrobial Peptides Market Size, 2017-2028
6.5.9 Benelux Antimicrobial Peptides Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Antimicrobial Peptides Revenue, 2017-2028
6.6.2 By Region - Asia Antimicrobial Peptides Sales, 2017-2028
6.6.3 China Antimicrobial Peptides Market Size, 2017-2028
6.6.4 Japan Antimicrobial Peptides Market Size, 2017-2028
6.6.5 South Korea Antimicrobial Peptides Market Size, 2017-2028
6.6.6 Southeast Asia Antimicrobial Peptides Market Size, 2017-2028
6.6.7 India Antimicrobial Peptides Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Antimicrobial Peptides Revenue, 2017-2028
6.7.2 By Country - South America Antimicrobial Peptides Sales, 2017-2028
6.7.3 Brazil Antimicrobial Peptides Market Size, 2017-2028
6.7.4 Argentina Antimicrobial Peptides Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Antimicrobial Peptides Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Antimicrobial Peptides Sales, 2017-2028
6.8.3 Turkey Antimicrobial Peptides Market Size, 2017-2028
6.8.4 Israel Antimicrobial Peptides Market Size, 2017-2028
6.8.5 Saudi Arabia Antimicrobial Peptides Market Size, 2017-2028
6.8.6 UAE Antimicrobial Peptides Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 AnaSpec
7.1.1 AnaSpec Corporate Summary
7.1.2 AnaSpec Business Overview
7.1.3 AnaSpec Antimicrobial Peptides Major Product Offerings
7.1.4 AnaSpec Antimicrobial Peptides Sales and Revenue in Global (2017-2022)
7.1.5 AnaSpec Key News
7.2 AMP Biotech
7.2.1 AMP Biotech Corporate Summary
7.2.2 AMP Biotech Business Overview
7.2.3 AMP Biotech Antimicrobial Peptides Major Product Offerings
7.2.4 AMP Biotech Antimicrobial Peptides Sales and Revenue in Global (2017-2022)
7.2.5 AMP Biotech Key News
7.3 Phoenix Biotech
7.3.1 Phoenix Biotech Corporate Summary
7.3.2 Phoenix Biotech Business Overview
7.3.3 Phoenix Biotech Antimicrobial Peptides Major Product Offerings
7.3.4 Phoenix Biotech Antimicrobial Peptides Sales and Revenue in Global (2017-2022)
7.3.5 Phoenix Biotech Key News
7.4 Novabiotics
7.4.1 Novabiotics Corporate Summary
7.4.2 Novabiotics Business Overview
7.4.3 Novabiotics Antimicrobial Peptides Major Product Offerings
7.4.4 Novabiotics Antimicrobial Peptides Sales and Revenue in Global (2017-2022)
7.4.5 Novabiotics Key News
7.5 Chinese Peptide
7.5.1 Chinese Peptide Corporate Summary
7.5.2 Chinese Peptide Business Overview
7.5.3 Chinese Peptide Antimicrobial Peptides Major Product Offerings
7.5.4 Chinese Peptide Antimicrobial Peptides Sales and Revenue in Global (2017-2022)
7.5.5 Chinese Peptide Key News
7.6 Ontores
7.6.1 Ontores Corporate Summary
7.6.2 Ontores Business Overview
7.6.3 Ontores Antimicrobial Peptides Major Product Offerings
7.6.4 Ontores Antimicrobial Peptides Sales and Revenue in Global (2017-2022)
7.6.5 Ontores Key News
7.7 GenScript
7.7.1 GenScript Corporate Summary
7.7.2 GenScript Business Overview
7.7.3 GenScript Antimicrobial Peptides Major Product Offerings
7.7.4 GenScript Antimicrobial Peptides Sales and Revenue in Global (2017-2022)
7.7.5 GenScript Key News
7.8 Hycult Biotech
7.8.1 Hycult Biotech Corporate Summary
7.8.2 Hycult Biotech Business Overview
7.8.3 Hycult Biotech Antimicrobial Peptides Major Product Offerings
7.8.4 Hycult Biotech Antimicrobial Peptides Sales and Revenue in Global (2017-2022)
7.8.5 Hycult Biotech Key News
7.9 Sunsmile
7.9.1 Sunsmile Corporate Summary
7.9.2 Sunsmile Business Overview
7.9.3 Sunsmile Antimicrobial Peptides Major Product Offerings
7.9.4 Sunsmile Antimicrobial Peptides Sales and Revenue in Global (2017-2022)
7.9.5 Sunsmile Key News
7.10 Ruixing Biotechnology
7.10.1 Ruixing Biotechnology Corporate Summary
7.10.2 Ruixing Biotechnology Business Overview
7.10.3 Ruixing Biotechnology Antimicrobial Peptides Major Product Offerings
7.10.4 Ruixing Biotechnology Antimicrobial Peptides Sales and Revenue in Global (2017-2022)
7.10.5 Ruixing Biotechnology Key News
7.11 Zhongnong Yingtai Biotechnology
7.11.1 Zhongnong Yingtai Biotechnology Corporate Summary
7.11.2 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Business Overview
7.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Major Product Offerings
7.11.4 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales and Revenue in Global (2017-2022)
7.11.5 Zhongnong Yingtai Biotechnology Key News
7.12 Glam Technology
7.12.1 Glam Technology Corporate Summary
7.12.2 Glam Technology Antimicrobial Peptides Business Overview
7.12.3 Glam Technology Antimicrobial Peptides Major Product Offerings
7.12.4 Glam Technology Antimicrobial Peptides Sales and Revenue in Global (2017-2022)
7.12.5 Glam Technology Key News
7.13 ProteLight Pharmaceutical & Biotechnology
7.13.1 ProteLight Pharmaceutical & Biotechnology Corporate Summary
7.13.2 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Business Overview
7.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Major Product Offerings
7.13.4 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales and Revenue in Global (2017-2022)
7.13.5 ProteLight Pharmaceutical & Biotechnology Key News
8 GLOBAL ANTIMICROBIAL PEPTIDES PRODUCTION CAPACITY, ANALYSIS
8.1 Global Antimicrobial Peptides Production Capacity, 2017-2028
8.2 Antimicrobial Peptides Production Capacity of Key Manufacturers in Global Market
8.3 Global Antimicrobial Peptides Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 ANTIMICROBIAL PEPTIDES SUPPLY CHAIN ANALYSIS
10.1 Antimicrobial Peptides Industry Value Chain
10.2 Antimicrobial Peptides Upstream Market
10.3 Antimicrobial Peptides Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antimicrobial Peptides Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Antimicrobial Peptides Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antimicrobial Peptides Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL ANTIMICROBIAL PEPTIDES OVERALL MARKET SIZE
2.1 Global Antimicrobial Peptides Market Size: 2021 VS 2028
2.2 Global Antimicrobial Peptides Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Antimicrobial Peptides Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Antimicrobial Peptides Players in Global Market
3.2 Top Global Antimicrobial Peptides Companies Ranked by Revenue
3.3 Global Antimicrobial Peptides Revenue by Companies
3.4 Global Antimicrobial Peptides Sales by Companies
3.5 Global Antimicrobial Peptides Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Antimicrobial Peptides Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Antimicrobial Peptides Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antimicrobial Peptides Players in Global Market
3.8.1 List of Global Tier 1 Antimicrobial Peptides Companies
3.8.2 List of Global Tier 2 and Tier 3 Antimicrobial Peptides Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Antimicrobial Peptides Market Size Markets, 2021 & 2028
4.1.2 Plant Antimicrobial Peptides
4.1.3 Microbial Antimicrobial Peptides
4.1.4 Animal Antimicrobial Peptides
4.2 By Type - Global Antimicrobial Peptides Revenue & Forecasts
4.2.1 By Type - Global Antimicrobial Peptides Revenue, 2017-2022
4.2.2 By Type - Global Antimicrobial Peptides Revenue, 2023-2028
4.2.3 By Type - Global Antimicrobial Peptides Revenue Market Share, 2017-2028
4.3 By Type - Global Antimicrobial Peptides Sales & Forecasts
4.3.1 By Type - Global Antimicrobial Peptides Sales, 2017-2022
4.3.2 By Type - Global Antimicrobial Peptides Sales, 2023-2028
4.3.3 By Type - Global Antimicrobial Peptides Sales Market Share, 2017-2028
4.4 By Type - Global Antimicrobial Peptides Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Antimicrobial Peptides Market Size, 2021 & 2028
5.1.2 Pharmaceuticals
5.1.3 Feed Additives
5.1.4 Others
5.2 By Application - Global Antimicrobial Peptides Revenue & Forecasts
5.2.1 By Application - Global Antimicrobial Peptides Revenue, 2017-2022
5.2.2 By Application - Global Antimicrobial Peptides Revenue, 2023-2028
5.2.3 By Application - Global Antimicrobial Peptides Revenue Market Share, 2017-2028
5.3 By Application - Global Antimicrobial Peptides Sales & Forecasts
5.3.1 By Application - Global Antimicrobial Peptides Sales, 2017-2022
5.3.2 By Application - Global Antimicrobial Peptides Sales, 2023-2028
5.3.3 By Application - Global Antimicrobial Peptides Sales Market Share, 2017-2028
5.4 By Application - Global Antimicrobial Peptides Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Antimicrobial Peptides Market Size, 2021 & 2028
6.2 By Region - Global Antimicrobial Peptides Revenue & Forecasts
6.2.1 By Region - Global Antimicrobial Peptides Revenue, 2017-2022
6.2.2 By Region - Global Antimicrobial Peptides Revenue, 2023-2028
6.2.3 By Region - Global Antimicrobial Peptides Revenue Market Share, 2017-2028
6.3 By Region - Global Antimicrobial Peptides Sales & Forecasts
6.3.1 By Region - Global Antimicrobial Peptides Sales, 2017-2022
6.3.2 By Region - Global Antimicrobial Peptides Sales, 2023-2028
6.3.3 By Region - Global Antimicrobial Peptides Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Antimicrobial Peptides Revenue, 2017-2028
6.4.2 By Country - North America Antimicrobial Peptides Sales, 2017-2028
6.4.3 US Antimicrobial Peptides Market Size, 2017-2028
6.4.4 Canada Antimicrobial Peptides Market Size, 2017-2028
6.4.5 Mexico Antimicrobial Peptides Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Antimicrobial Peptides Revenue, 2017-2028
6.5.2 By Country - Europe Antimicrobial Peptides Sales, 2017-2028
6.5.3 Germany Antimicrobial Peptides Market Size, 2017-2028
6.5.4 France Antimicrobial Peptides Market Size, 2017-2028
6.5.5 U.K. Antimicrobial Peptides Market Size, 2017-2028
6.5.6 Italy Antimicrobial Peptides Market Size, 2017-2028
6.5.7 Russia Antimicrobial Peptides Market Size, 2017-2028
6.5.8 Nordic Countries Antimicrobial Peptides Market Size, 2017-2028
6.5.9 Benelux Antimicrobial Peptides Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Antimicrobial Peptides Revenue, 2017-2028
6.6.2 By Region - Asia Antimicrobial Peptides Sales, 2017-2028
6.6.3 China Antimicrobial Peptides Market Size, 2017-2028
6.6.4 Japan Antimicrobial Peptides Market Size, 2017-2028
6.6.5 South Korea Antimicrobial Peptides Market Size, 2017-2028
6.6.6 Southeast Asia Antimicrobial Peptides Market Size, 2017-2028
6.6.7 India Antimicrobial Peptides Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Antimicrobial Peptides Revenue, 2017-2028
6.7.2 By Country - South America Antimicrobial Peptides Sales, 2017-2028
6.7.3 Brazil Antimicrobial Peptides Market Size, 2017-2028
6.7.4 Argentina Antimicrobial Peptides Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Antimicrobial Peptides Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Antimicrobial Peptides Sales, 2017-2028
6.8.3 Turkey Antimicrobial Peptides Market Size, 2017-2028
6.8.4 Israel Antimicrobial Peptides Market Size, 2017-2028
6.8.5 Saudi Arabia Antimicrobial Peptides Market Size, 2017-2028
6.8.6 UAE Antimicrobial Peptides Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 AnaSpec
7.1.1 AnaSpec Corporate Summary
7.1.2 AnaSpec Business Overview
7.1.3 AnaSpec Antimicrobial Peptides Major Product Offerings
7.1.4 AnaSpec Antimicrobial Peptides Sales and Revenue in Global (2017-2022)
7.1.5 AnaSpec Key News
7.2 AMP Biotech
7.2.1 AMP Biotech Corporate Summary
7.2.2 AMP Biotech Business Overview
7.2.3 AMP Biotech Antimicrobial Peptides Major Product Offerings
7.2.4 AMP Biotech Antimicrobial Peptides Sales and Revenue in Global (2017-2022)
7.2.5 AMP Biotech Key News
7.3 Phoenix Biotech
7.3.1 Phoenix Biotech Corporate Summary
7.3.2 Phoenix Biotech Business Overview
7.3.3 Phoenix Biotech Antimicrobial Peptides Major Product Offerings
7.3.4 Phoenix Biotech Antimicrobial Peptides Sales and Revenue in Global (2017-2022)
7.3.5 Phoenix Biotech Key News
7.4 Novabiotics
7.4.1 Novabiotics Corporate Summary
7.4.2 Novabiotics Business Overview
7.4.3 Novabiotics Antimicrobial Peptides Major Product Offerings
7.4.4 Novabiotics Antimicrobial Peptides Sales and Revenue in Global (2017-2022)
7.4.5 Novabiotics Key News
7.5 Chinese Peptide
7.5.1 Chinese Peptide Corporate Summary
7.5.2 Chinese Peptide Business Overview
7.5.3 Chinese Peptide Antimicrobial Peptides Major Product Offerings
7.5.4 Chinese Peptide Antimicrobial Peptides Sales and Revenue in Global (2017-2022)
7.5.5 Chinese Peptide Key News
7.6 Ontores
7.6.1 Ontores Corporate Summary
7.6.2 Ontores Business Overview
7.6.3 Ontores Antimicrobial Peptides Major Product Offerings
7.6.4 Ontores Antimicrobial Peptides Sales and Revenue in Global (2017-2022)
7.6.5 Ontores Key News
7.7 GenScript
7.7.1 GenScript Corporate Summary
7.7.2 GenScript Business Overview
7.7.3 GenScript Antimicrobial Peptides Major Product Offerings
7.7.4 GenScript Antimicrobial Peptides Sales and Revenue in Global (2017-2022)
7.7.5 GenScript Key News
7.8 Hycult Biotech
7.8.1 Hycult Biotech Corporate Summary
7.8.2 Hycult Biotech Business Overview
7.8.3 Hycult Biotech Antimicrobial Peptides Major Product Offerings
7.8.4 Hycult Biotech Antimicrobial Peptides Sales and Revenue in Global (2017-2022)
7.8.5 Hycult Biotech Key News
7.9 Sunsmile
7.9.1 Sunsmile Corporate Summary
7.9.2 Sunsmile Business Overview
7.9.3 Sunsmile Antimicrobial Peptides Major Product Offerings
7.9.4 Sunsmile Antimicrobial Peptides Sales and Revenue in Global (2017-2022)
7.9.5 Sunsmile Key News
7.10 Ruixing Biotechnology
7.10.1 Ruixing Biotechnology Corporate Summary
7.10.2 Ruixing Biotechnology Business Overview
7.10.3 Ruixing Biotechnology Antimicrobial Peptides Major Product Offerings
7.10.4 Ruixing Biotechnology Antimicrobial Peptides Sales and Revenue in Global (2017-2022)
7.10.5 Ruixing Biotechnology Key News
7.11 Zhongnong Yingtai Biotechnology
7.11.1 Zhongnong Yingtai Biotechnology Corporate Summary
7.11.2 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Business Overview
7.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Major Product Offerings
7.11.4 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales and Revenue in Global (2017-2022)
7.11.5 Zhongnong Yingtai Biotechnology Key News
7.12 Glam Technology
7.12.1 Glam Technology Corporate Summary
7.12.2 Glam Technology Antimicrobial Peptides Business Overview
7.12.3 Glam Technology Antimicrobial Peptides Major Product Offerings
7.12.4 Glam Technology Antimicrobial Peptides Sales and Revenue in Global (2017-2022)
7.12.5 Glam Technology Key News
7.13 ProteLight Pharmaceutical & Biotechnology
7.13.1 ProteLight Pharmaceutical & Biotechnology Corporate Summary
7.13.2 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Business Overview
7.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Major Product Offerings
7.13.4 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales and Revenue in Global (2017-2022)
7.13.5 ProteLight Pharmaceutical & Biotechnology Key News
8 GLOBAL ANTIMICROBIAL PEPTIDES PRODUCTION CAPACITY, ANALYSIS
8.1 Global Antimicrobial Peptides Production Capacity, 2017-2028
8.2 Antimicrobial Peptides Production Capacity of Key Manufacturers in Global Market
8.3 Global Antimicrobial Peptides Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 ANTIMICROBIAL PEPTIDES SUPPLY CHAIN ANALYSIS
10.1 Antimicrobial Peptides Industry Value Chain
10.2 Antimicrobial Peptides Upstream Market
10.3 Antimicrobial Peptides Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antimicrobial Peptides Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Antimicrobial Peptides in Global Market
Table 2. Top Antimicrobial Peptides Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Antimicrobial Peptides Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Antimicrobial Peptides Revenue Share by Companies, 2017-2022
Table 5. Global Antimicrobial Peptides Sales by Companies, (Mg), 2017-2022
Table 6. Global Antimicrobial Peptides Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Antimicrobial Peptides Price (2017-2022) & (US$/Mg)
Table 8. Global Manufacturers Antimicrobial Peptides Product Type
Table 9. List of Global Tier 1 Antimicrobial Peptides Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antimicrobial Peptides Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antimicrobial Peptides Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Antimicrobial Peptides Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Antimicrobial Peptides Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Antimicrobial Peptides Sales (Mg), 2017-2022
Table 15. By Type - Global Antimicrobial Peptides Sales (Mg), 2023-2028
Table 16. By Application – Global Antimicrobial Peptides Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Antimicrobial Peptides Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Antimicrobial Peptides Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Antimicrobial Peptides Sales (Mg), 2017-2022
Table 20. By Application - Global Antimicrobial Peptides Sales (Mg), 2023-2028
Table 21. By Region – Global Antimicrobial Peptides Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Antimicrobial Peptides Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Antimicrobial Peptides Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Antimicrobial Peptides Sales (Mg), 2017-2022
Table 25. By Region - Global Antimicrobial Peptides Sales (Mg), 2023-2028
Table 26. By Country - North America Antimicrobial Peptides Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Antimicrobial Peptides Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Antimicrobial Peptides Sales, (Mg), 2017-2022
Table 29. By Country - North America Antimicrobial Peptides Sales, (Mg), 2023-2028
Table 30. By Country - Europe Antimicrobial Peptides Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Antimicrobial Peptides Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Antimicrobial Peptides Sales, (Mg), 2017-2022
Table 33. By Country - Europe Antimicrobial Peptides Sales, (Mg), 2023-2028
Table 34. By Region - Asia Antimicrobial Peptides Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Antimicrobial Peptides Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Antimicrobial Peptides Sales, (Mg), 2017-2022
Table 37. By Region - Asia Antimicrobial Peptides Sales, (Mg), 2023-2028
Table 38. By Country - South America Antimicrobial Peptides Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Antimicrobial Peptides Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Antimicrobial Peptides Sales, (Mg), 2017-2022
Table 41. By Country - South America Antimicrobial Peptides Sales, (Mg), 2023-2028
Table 42. By Country - Middle East & Africa Antimicrobial Peptides Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Antimicrobial Peptides Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Antimicrobial Peptides Sales, (Mg), 2017-2022
Table 45. By Country - Middle East & Africa Antimicrobial Peptides Sales, (Mg), 2023-2028
Table 46. AnaSpec Corporate Summary
Table 47. AnaSpec Antimicrobial Peptides Product Offerings
Table 48. AnaSpec Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Average Price (US$/Mg) (2017-2022)
Table 49. AMP Biotech Corporate Summary
Table 50. AMP Biotech Antimicrobial Peptides Product Offerings
Table 51. AMP Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Average Price (US$/Mg) (2017-2022)
Table 52. Phoenix Biotech Corporate Summary
Table 53. Phoenix Biotech Antimicrobial Peptides Product Offerings
Table 54. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Average Price (US$/Mg) (2017-2022)
Table 55. Novabiotics Corporate Summary
Table 56. Novabiotics Antimicrobial Peptides Product Offerings
Table 57. Novabiotics Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Average Price (US$/Mg) (2017-2022)
Table 58. Chinese Peptide Corporate Summary
Table 59. Chinese Peptide Antimicrobial Peptides Product Offerings
Table 60. Chinese Peptide Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Average Price (US$/Mg) (2017-2022)
Table 61. Ontores Corporate Summary
Table 62. Ontores Antimicrobial Peptides Product Offerings
Table 63. Ontores Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Average Price (US$/Mg) (2017-2022)
Table 64. GenScript Corporate Summary
Table 65. GenScript Antimicrobial Peptides Product Offerings
Table 66. GenScript Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Average Price (US$/Mg) (2017-2022)
Table 67. Hycult Biotech Corporate Summary
Table 68. Hycult Biotech Antimicrobial Peptides Product Offerings
Table 69. Hycult Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Average Price (US$/Mg) (2017-2022)
Table 70. Sunsmile Corporate Summary
Table 71. Sunsmile Antimicrobial Peptides Product Offerings
Table 72. Sunsmile Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Average Price (US$/Mg) (2017-2022)
Table 73. Ruixing Biotechnology Corporate Summary
Table 74. Ruixing Biotechnology Antimicrobial Peptides Product Offerings
Table 75. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Average Price (US$/Mg) (2017-2022)
Table 76. Zhongnong Yingtai Biotechnology Corporate Summary
Table 77. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product Offerings
Table 78. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Average Price (US$/Mg) (2017-2022)
Table 79. Glam Technology Corporate Summary
Table 80. Glam Technology Antimicrobial Peptides Product Offerings
Table 81. Glam Technology Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Average Price (US$/Mg) (2017-2022)
Table 82. ProteLight Pharmaceutical & Biotechnology Corporate Summary
Table 83. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product Offerings
Table 84. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Average Price (US$/Mg) (2017-2022)
Table 85. Antimicrobial Peptides Production Capacity (Mg) of Key Manufacturers in Global Market, 2020-2022 (Mg)
Table 86. Global Antimicrobial Peptides Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Antimicrobial Peptides Production by Region, 2017-2022 (Mg)
Table 88. Global Antimicrobial Peptides Production by Region, 2023-2028 (Mg)
Table 89. Antimicrobial Peptides Market Opportunities & Trends in Global Market
Table 90. Antimicrobial Peptides Market Drivers in Global Market
Table 91. Antimicrobial Peptides Market Restraints in Global Market
Table 92. Antimicrobial Peptides Raw Materials
Table 93. Antimicrobial Peptides Raw Materials Suppliers in Global Market
Table 94. Typical Antimicrobial Peptides Downstream
Table 95. Antimicrobial Peptides Downstream Clients in Global Market
Table 96. Antimicrobial Peptides Distributors and Sales Agents in Global Market
Table 1. Key Players of Antimicrobial Peptides in Global Market
Table 2. Top Antimicrobial Peptides Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Antimicrobial Peptides Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Antimicrobial Peptides Revenue Share by Companies, 2017-2022
Table 5. Global Antimicrobial Peptides Sales by Companies, (Mg), 2017-2022
Table 6. Global Antimicrobial Peptides Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Antimicrobial Peptides Price (2017-2022) & (US$/Mg)
Table 8. Global Manufacturers Antimicrobial Peptides Product Type
Table 9. List of Global Tier 1 Antimicrobial Peptides Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antimicrobial Peptides Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antimicrobial Peptides Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Antimicrobial Peptides Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Antimicrobial Peptides Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Antimicrobial Peptides Sales (Mg), 2017-2022
Table 15. By Type - Global Antimicrobial Peptides Sales (Mg), 2023-2028
Table 16. By Application – Global Antimicrobial Peptides Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Antimicrobial Peptides Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Antimicrobial Peptides Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Antimicrobial Peptides Sales (Mg), 2017-2022
Table 20. By Application - Global Antimicrobial Peptides Sales (Mg), 2023-2028
Table 21. By Region – Global Antimicrobial Peptides Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Antimicrobial Peptides Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Antimicrobial Peptides Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Antimicrobial Peptides Sales (Mg), 2017-2022
Table 25. By Region - Global Antimicrobial Peptides Sales (Mg), 2023-2028
Table 26. By Country - North America Antimicrobial Peptides Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Antimicrobial Peptides Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Antimicrobial Peptides Sales, (Mg), 2017-2022
Table 29. By Country - North America Antimicrobial Peptides Sales, (Mg), 2023-2028
Table 30. By Country - Europe Antimicrobial Peptides Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Antimicrobial Peptides Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Antimicrobial Peptides Sales, (Mg), 2017-2022
Table 33. By Country - Europe Antimicrobial Peptides Sales, (Mg), 2023-2028
Table 34. By Region - Asia Antimicrobial Peptides Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Antimicrobial Peptides Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Antimicrobial Peptides Sales, (Mg), 2017-2022
Table 37. By Region - Asia Antimicrobial Peptides Sales, (Mg), 2023-2028
Table 38. By Country - South America Antimicrobial Peptides Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Antimicrobial Peptides Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Antimicrobial Peptides Sales, (Mg), 2017-2022
Table 41. By Country - South America Antimicrobial Peptides Sales, (Mg), 2023-2028
Table 42. By Country - Middle East & Africa Antimicrobial Peptides Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Antimicrobial Peptides Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Antimicrobial Peptides Sales, (Mg), 2017-2022
Table 45. By Country - Middle East & Africa Antimicrobial Peptides Sales, (Mg), 2023-2028
Table 46. AnaSpec Corporate Summary
Table 47. AnaSpec Antimicrobial Peptides Product Offerings
Table 48. AnaSpec Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Average Price (US$/Mg) (2017-2022)
Table 49. AMP Biotech Corporate Summary
Table 50. AMP Biotech Antimicrobial Peptides Product Offerings
Table 51. AMP Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Average Price (US$/Mg) (2017-2022)
Table 52. Phoenix Biotech Corporate Summary
Table 53. Phoenix Biotech Antimicrobial Peptides Product Offerings
Table 54. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Average Price (US$/Mg) (2017-2022)
Table 55. Novabiotics Corporate Summary
Table 56. Novabiotics Antimicrobial Peptides Product Offerings
Table 57. Novabiotics Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Average Price (US$/Mg) (2017-2022)
Table 58. Chinese Peptide Corporate Summary
Table 59. Chinese Peptide Antimicrobial Peptides Product Offerings
Table 60. Chinese Peptide Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Average Price (US$/Mg) (2017-2022)
Table 61. Ontores Corporate Summary
Table 62. Ontores Antimicrobial Peptides Product Offerings
Table 63. Ontores Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Average Price (US$/Mg) (2017-2022)
Table 64. GenScript Corporate Summary
Table 65. GenScript Antimicrobial Peptides Product Offerings
Table 66. GenScript Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Average Price (US$/Mg) (2017-2022)
Table 67. Hycult Biotech Corporate Summary
Table 68. Hycult Biotech Antimicrobial Peptides Product Offerings
Table 69. Hycult Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Average Price (US$/Mg) (2017-2022)
Table 70. Sunsmile Corporate Summary
Table 71. Sunsmile Antimicrobial Peptides Product Offerings
Table 72. Sunsmile Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Average Price (US$/Mg) (2017-2022)
Table 73. Ruixing Biotechnology Corporate Summary
Table 74. Ruixing Biotechnology Antimicrobial Peptides Product Offerings
Table 75. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Average Price (US$/Mg) (2017-2022)
Table 76. Zhongnong Yingtai Biotechnology Corporate Summary
Table 77. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product Offerings
Table 78. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Average Price (US$/Mg) (2017-2022)
Table 79. Glam Technology Corporate Summary
Table 80. Glam Technology Antimicrobial Peptides Product Offerings
Table 81. Glam Technology Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Average Price (US$/Mg) (2017-2022)
Table 82. ProteLight Pharmaceutical & Biotechnology Corporate Summary
Table 83. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product Offerings
Table 84. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Average Price (US$/Mg) (2017-2022)
Table 85. Antimicrobial Peptides Production Capacity (Mg) of Key Manufacturers in Global Market, 2020-2022 (Mg)
Table 86. Global Antimicrobial Peptides Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Antimicrobial Peptides Production by Region, 2017-2022 (Mg)
Table 88. Global Antimicrobial Peptides Production by Region, 2023-2028 (Mg)
Table 89. Antimicrobial Peptides Market Opportunities & Trends in Global Market
Table 90. Antimicrobial Peptides Market Drivers in Global Market
Table 91. Antimicrobial Peptides Market Restraints in Global Market
Table 92. Antimicrobial Peptides Raw Materials
Table 93. Antimicrobial Peptides Raw Materials Suppliers in Global Market
Table 94. Typical Antimicrobial Peptides Downstream
Table 95. Antimicrobial Peptides Downstream Clients in Global Market
Table 96. Antimicrobial Peptides Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Antimicrobial Peptides Segment by Type
Figure 2. Antimicrobial Peptides Segment by Application
Figure 3. Global Antimicrobial Peptides Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Antimicrobial Peptides Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antimicrobial Peptides Revenue, 2017-2028 (US$, Mn)
Figure 7. Antimicrobial Peptides Sales in Global Market: 2017-2028 (Mg)
Figure 8. The Top 3 and 5 Players Market Share by Antimicrobial Peptides Revenue in 2021
Figure 9. By Type - Global Antimicrobial Peptides Sales Market Share, 2017-2028
Figure 10. By Type - Global Antimicrobial Peptides Revenue Market Share, 2017-2028
Figure 11. By Type - Global Antimicrobial Peptides Price (US$/Mg), 2017-2028
Figure 12. By Application - Global Antimicrobial Peptides Sales Market Share, 2017-2028
Figure 13. By Application - Global Antimicrobial Peptides Revenue Market Share, 2017-2028
Figure 14. By Application - Global Antimicrobial Peptides Price (US$/Mg), 2017-2028
Figure 15. By Region - Global Antimicrobial Peptides Sales Market Share, 2017-2028
Figure 16. By Region - Global Antimicrobial Peptides Revenue Market Share, 2017-2028
Figure 17. By Country - North America Antimicrobial Peptides Revenue Market Share, 2017-2028
Figure 18. By Country - North America Antimicrobial Peptides Sales Market Share, 2017-2028
Figure 19. US Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Antimicrobial Peptides Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Antimicrobial Peptides Sales Market Share, 2017-2028
Figure 24. Germany Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 25. France Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Antimicrobial Peptides Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Antimicrobial Peptides Sales Market Share, 2017-2028
Figure 33. China Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 37. India Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Antimicrobial Peptides Revenue Market Share, 2017-2028
Figure 39. By Country - South America Antimicrobial Peptides Sales Market Share, 2017-2028
Figure 40. Brazil Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Antimicrobial Peptides Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Antimicrobial Peptides Sales Market Share, 2017-2028
Figure 44. Turkey Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 48. Global Antimicrobial Peptides Production Capacity (Mg), 2017-2028
Figure 49. The Percentage of Production Antimicrobial Peptides by Region, 2020 VS 2027
Figure 50. Antimicrobial Peptides Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Antimicrobial Peptides Segment by Type
Figure 2. Antimicrobial Peptides Segment by Application
Figure 3. Global Antimicrobial Peptides Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Antimicrobial Peptides Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antimicrobial Peptides Revenue, 2017-2028 (US$, Mn)
Figure 7. Antimicrobial Peptides Sales in Global Market: 2017-2028 (Mg)
Figure 8. The Top 3 and 5 Players Market Share by Antimicrobial Peptides Revenue in 2021
Figure 9. By Type - Global Antimicrobial Peptides Sales Market Share, 2017-2028
Figure 10. By Type - Global Antimicrobial Peptides Revenue Market Share, 2017-2028
Figure 11. By Type - Global Antimicrobial Peptides Price (US$/Mg), 2017-2028
Figure 12. By Application - Global Antimicrobial Peptides Sales Market Share, 2017-2028
Figure 13. By Application - Global Antimicrobial Peptides Revenue Market Share, 2017-2028
Figure 14. By Application - Global Antimicrobial Peptides Price (US$/Mg), 2017-2028
Figure 15. By Region - Global Antimicrobial Peptides Sales Market Share, 2017-2028
Figure 16. By Region - Global Antimicrobial Peptides Revenue Market Share, 2017-2028
Figure 17. By Country - North America Antimicrobial Peptides Revenue Market Share, 2017-2028
Figure 18. By Country - North America Antimicrobial Peptides Sales Market Share, 2017-2028
Figure 19. US Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Antimicrobial Peptides Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Antimicrobial Peptides Sales Market Share, 2017-2028
Figure 24. Germany Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 25. France Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Antimicrobial Peptides Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Antimicrobial Peptides Sales Market Share, 2017-2028
Figure 33. China Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 37. India Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Antimicrobial Peptides Revenue Market Share, 2017-2028
Figure 39. By Country - South America Antimicrobial Peptides Sales Market Share, 2017-2028
Figure 40. Brazil Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Antimicrobial Peptides Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Antimicrobial Peptides Sales Market Share, 2017-2028
Figure 44. Turkey Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Antimicrobial Peptides Revenue, (US$, Mn), 2017-2028
Figure 48. Global Antimicrobial Peptides Production Capacity (Mg), 2017-2028
Figure 49. The Percentage of Production Antimicrobial Peptides by Region, 2020 VS 2027
Figure 50. Antimicrobial Peptides Industry Value Chain
Figure 51. Marketing Channels
